Luminate Medical vs athenahealth
Side-by-side comparison of AI visibility scores, market position, and capabilities
Dublin oncology device company developing at-home scalp cooling to prevent chemo hair loss; $22M YC and 8VC-backed with $15M Atlantic Bridge Series A pursuing FDA clearance for at-home oncology care model.
About
Luminate Medical is a Dublin, Ireland-based healthcare technology company developing patient-centered oncology care devices — most notably a next-generation scalp cooling system that prevents or reduces chemotherapy-induced hair loss (alopecia), one of the most psychologically distressing side effects of cancer treatment. Backed by Y Combinator, 8VC, and Atlantic Bridge with $22 million raised total including a $15 million Series A led by Atlantic Bridge in 2024 and a €6.4 million Irish Government grant in 2025, Luminate is pursuing FDA clearance for US market entry with first commercial revenues expected in 2025.
$1.7B annual revenue; 160K+ providers, 117M patients; 18.15% EHR market share; 6,713+ companies using 2025; acquired by Bain Capital & Hellman & Friedman Nov 2021 at $17B; AI interoperability 2025
About
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on the principle that healthcare administration should be managed as a service — with athenahealth absorbing the complexity of payer rule updates, regulatory compliance, and billing workflows so that physicians and clinical staff can focus entirely on patient care. Its cloud-native architecture, deployed before most EHR competitors moved to the cloud, remains a core technical differentiator.\n\nathenahealth's platform — athenaOne — integrates EHR, revenue cycle management, patient engagement, and care coordination in a single system used by over 160,000 providers across 117 million patient records. The company serves ambulatory practices ranging from solo physicians to large health systems and medical groups. Its continuously updated rules engine processes millions of payer transactions daily, enabling higher clean claim rates and faster reimbursement compared to on-premise EHR alternatives. athenahealth holds an 18.15% share of the US ambulatory EHR market.\n\nathenahealth is currently owned by a private equity consortium of Bain Capital and Hellman & Friedman, which acquired the company in 2019 for $5.7 billion. Annual revenue stands at approximately $1.7 billion. The company competes with Epic, eClinicalWorks, and Oracle Health in the ambulatory EHR market. Its managed-service model, shared payer network data, and cloud-native infrastructure continue to make it a compelling choice for ambulatory providers who prioritize revenue cycle performance and reduced administrative burden.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.